Results 101 to 110 of about 5,095,858 (271)

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

open access: yesArthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos   +2 more
wiley   +1 more source

High - and low-impact citation measures: empirical applications [PDF]

open access: yes
This paper contains the first empirical applications of a novel methodology for comparing the citation distributions of research units working in the same homogeneous field.
Javier Ruiz-Castillo   +2 more
core   +2 more sources

33 Tips to Maximize Articles’ Citation Frequency [PDF]

open access: yes, 2014
The number of citations contributes to over 30% in the university rankings. Therefore, most of the scientists are looking for an effective method to increase their citation record.
Ale Ebrahim, Nader (409259)   +2 more
core   +1 more source

Physician‐Scientist Pipeline for Pediatric Rheumatology: The Current Landscape and Future Perspectives

open access: yesArthritis Care &Research, EarlyView.
Over the past 50 years, the science of pediatric rheumatology has grown exponentially due to an expansion in the understanding of complex rheumatic conditions and a surge in novel targeted therapeutics. Physician‐scientists in the field of pediatric rheumatology have played major roles in these advancements that have improved the care of children ...
Ekemini A. Ogbu   +2 more
wiley   +1 more source

Emerging trends of research on mRNA vaccines: A co-citation analysis. [PDF]

open access: yesHum Vaccin Immunother, 2022
Chen J, Zhang T, Lu Y, Yang X, Ouyang Z.
europepmc   +1 more source

Artificial Intelligence–Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives

open access: yesArthritis Care &Research, EarlyView.
Objective The objective of this article is to identify perceptions of patients with systemic lupus erythematosus (SLE) regarding artificial intelligence (AI)–based online symptom assessment tools, and the potential of these tools to address diagnostic barriers.
Olivia A. Stein   +7 more
wiley   +1 more source

A New Framework for the Citation Indexing Paradigm [PDF]

open access: yes, 2006
A new citation indexing paradigm is proposed: the cascading citation indexing framework (c2IF, for short). It improves the way research publications are assessed for their impact in promoting science and technology.
Samaras, Nikolaos   +3 more
core   +1 more source

Publications on COVID-19 in radiology journals in 2020 and 2021: bibliometric citation and co-citation network analysis. [PDF]

open access: yesEur Radiol, 2023
Navarro-Ballester A   +3 more
europepmc   +1 more source

Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the EUSTAR Cohort

open access: yesArthritis Care &Research, EarlyView.
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato   +27 more
wiley   +1 more source

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

open access: yesArthritis Care &Research, EarlyView.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci   +25 more
wiley   +1 more source

Home - About - Disclaimer - Privacy